Taniwaki M, Yoshida M, Matsumoto Y, Shimura K, Kuroda J, Kaneko H. ELOTUZUMAB FOR THE TREATMENT OF RELAPSED OR REFRACTORY MULTIPLE MYELOMA, WITH SPECIAL REFERENCE TO ITS MODES OF ACTION AND SLAMF7 SIGNALING. Mediterr J Hematol Infect Dis [Internet]. 2018 Feb. 15 [cited 2024 Nov. 24];10(1):e2018014. Available from: https://www.mjhid.org/mjhid/article/view/2018.014